KRAS and neoplasm: In this current study, different sample types (A–E) and along with different tumor entities could also be compared like for example, case #8 (thyroid), #10 (melanoma)- NRAS/BRAF assay; case #16, #18, #19 (thyroid)-BRAF assay; case # 9 (esophagus), #14 (lung), #12 (lung), #15 (pancreas)–KRAS assay and case #41 (oropharynx), #42 (thyroid)–GeneFusion Assay.